Biohaven CEO on migraine drug's fast launch, TikTok ads and battling big pharma

Biohaven CEO on migraine drug's fast launch, TikTok ads and battling big pharma

Source: 
BioPharma Dive
snippet: 

Migraine sufferers in the U.S. found some relief over the past few years as a handful of new treatments came to market. The additions include a group of injectable drugs that help prevent the painful headaches, as well as a pill, Ubrelvy, which was cleared in late 2019 to alleviate migraines after they start.